0.3694USD-5.01%Mkt Cap: 23.21M $P/E: —1d ago
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship pro…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap23.21M $
Enterprise Value47.66M $
Revenue (TTM)37.20M $
Gross Profit26.49M $
Net Income (TTM)-8.20M $
Revenue/Share0.5930 USD
Last Price0.3694 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees129
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS23283X2062
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-4.00
EV/Revenue1.28
P/S0.62
P/B10.55
EPS (TTM)-0.19
EPS (Forward)0.00
52W Range
0.35042% of range1.220
52W High1.220 USD
52W Low0.3504 USD
Profitability
Gross Margin71.48%
Oper. Margin-34.34%
EBITDA Margin-32.04%
Profit Margin-22.12%
ROE-138.88%
ROA-18.56%
Growth
Revenue Growth1.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.38M $
CapEx (TTM)491.00K $
FCF Margin-13.31%
FCF Yield-21.33%
Net Debt24.46M $
Net Debt/EBITDA-2.05
Balance Sheet
Debt/Equity4.93
Current Ratio1.09
Quick Ratio0.73
Book Value/Sh0.0350 USD
Cash/Share0.0770 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateDec 5, 2014
Analyst Consensus
Rating—
Target (Mean)2.875 USD
Upside (mean)+678.3%
Target Range0.7500 USD – 5.000 USD
$0.7500+678.3% to mean$5.000
# Analysts2
Ownership
Shares Out.62.84M
Float53.94M
Insiders15.72%
Institutions26.39%
Short Interest
Short Ratio6.9d
Short % Float3.59%
Short % Out.3.31%
Shares Short2.08M
Short (prev mo.)2.07M
Technical
SMA 500.4644 (-20.4%)
SMA 2000.6517 (-43.3%)
Beta1.39
S&P 52W Chg20.25%
Avg Vol (30d)232.93K
Avg Vol (10d)79.86K
Technical Indicators
RSI (14)41.0
MACD-0.0241
MACD Signal-0.0254
MACD Hist.+0.0013
BB Upper0.4962 USD
BB Middle0.4109 USD
BB Lower0.3257 USD
BB Width41.51%
ATR (14)0.0496 USD
Vol Ratio (20d)0.31x